Answers are grounded in this paper and cite their sources.
Serum profiling reveals multivariate patterns of allergen-specific antibodies in peanut allergy, highlighting targets for immunotherapy.
Natascha Wuillemin, Chiara Arena, Dimitri Bieli and Tiziana Sonati are employees of Mabylon AG, which develops immunotherapies against peanut allergy. Thomas Kündig is scientific advisor to Mabylon AG. All other authors declare no conflict of interest. The data that support the findings of this study are available from the corresponding author upon reasonable request. Appendix S1. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
No takes yet. Share an insight, caveat, or question.
Paolucci et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: